The fusion energy landscape is evolving rapidly. Once confined to experimental research, fusion is now emerging as a strategic national priority for research and development. The IAEA World Fusion ...
Clinical Trials Arena on MSN
First patient dosed in Biomea Fusion’s Phase I trial of BMF-650 for obesity
In preclinical studies, BMF-650, administered once daily at 10mg/kg and 30mg/kg, reduced food intake and weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback